Coherus Biosciences | Ativos

Preço das Ações
2.11
Mudança Diária
0.05 2.43%
Mensal
27.88%
Anual
90.09%
Q1 Previsão
2.39




Ativos Alterar Data
AbbVie USD 133.9B 3.28B 2025-09
Acadia Pharmaceuticals USD 1.33B 105.22M 2025-09
Akebia Therapeutics USD 364.15M 18.56M 2025-09
ALKERMES USD 2.33B 76.7M 2025-09
Alnylam Pharmaceuticals USD 4.85B 285.64M 2025-09
Amarin USD 659.81M 10.31M 2025-09
Amgen USD 90.59B 445M 2025-12
Baxter International USD 21.07B 21M 2025-09
Biogen USD 29.44B 232M 2025-12
BioMarin Pharmaceutical USD 7.61B 158.53M 2025-09
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Coherus Biosciences USD 516.52M 77.05M 2025-09
Eli Lilly USD 114.94B 14.01B 2025-09
Fujifilm JPY 5.88T 349.29B 2025-12
Gilead Sciences USD 58.53B 2.81B 2025-09
Ironwood Pharmaceuticals USD 396.06M 53.12M 2025-09
Merck USD 129.55B 12.02B 2025-09
Myriad Genetics USD 728.1M 50.8M 2025-09
Pacira USD 1.3B 239.68M 2025-09
Perrigo USD 10.08B 10.1M 2025-09
Pfizer USD 208.73B 2.64B 2025-09
PTC Therapeutics USD 2.64B 9.54M 2025-09
Regeneron Pharmaceuticals USD 40.56B 389.3M 2025-12
Sarepta Therapeutics USD 3.49B 186.38M 2025-09
Teva Pharmaceutical Industries USD 40.75B 892M 2025-12
Vertex Pharmaceuticals USD 24.86B 825.6M 2025-09
Xencor USD 868.81M 10.61M 2025-09
Zoetis USD 15.16B 680M 2025-09


Coherus Biosciences Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.